Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate

Bibliographic Details
Main Authors: Clerico, M, Faggiano, F, Palace, J, Rice, G, Tintore, M, Durelli, L
Format: Conference item
Published: 2005
_version_ 1797066485234925568
author Clerico, M
Faggiano, F
Palace, J
Rice, G
Tintore, M
Durelli, L
author_facet Clerico, M
Faggiano, F
Palace, J
Rice, G
Tintore, M
Durelli, L
author_sort Clerico, M
collection OXFORD
description
first_indexed 2024-03-06T21:42:45Z
format Conference item
id oxford-uuid:487fc38a-9ee7-443f-9bbe-076953ef5001
institution University of Oxford
last_indexed 2024-03-06T21:42:45Z
publishDate 2005
record_format dspace
spelling oxford-uuid:487fc38a-9ee7-443f-9bbe-076953ef50012022-03-26T15:26:10ZTreatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetateConference itemhttp://purl.org/coar/resource_type/c_5794uuid:487fc38a-9ee7-443f-9bbe-076953ef5001Symplectic Elements at Oxford2005Clerico, MFaggiano, FPalace, JRice, GTintore, MDurelli, L
spellingShingle Clerico, M
Faggiano, F
Palace, J
Rice, G
Tintore, M
Durelli, L
Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate
title Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate
title_full Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate
title_fullStr Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate
title_full_unstemmed Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate
title_short Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate
title_sort treatment for delaying conversion of the first demyelinating event to multiple sclerosis a cochrane review on use of recombinant interferon beta or glatiramer acetate
work_keys_str_mv AT clericom treatmentfordelayingconversionofthefirstdemyelinatingeventtomultiplesclerosisacochranereviewonuseofrecombinantinterferonbetaorglatirameracetate
AT faggianof treatmentfordelayingconversionofthefirstdemyelinatingeventtomultiplesclerosisacochranereviewonuseofrecombinantinterferonbetaorglatirameracetate
AT palacej treatmentfordelayingconversionofthefirstdemyelinatingeventtomultiplesclerosisacochranereviewonuseofrecombinantinterferonbetaorglatirameracetate
AT riceg treatmentfordelayingconversionofthefirstdemyelinatingeventtomultiplesclerosisacochranereviewonuseofrecombinantinterferonbetaorglatirameracetate
AT tintorem treatmentfordelayingconversionofthefirstdemyelinatingeventtomultiplesclerosisacochranereviewonuseofrecombinantinterferonbetaorglatirameracetate
AT durellil treatmentfordelayingconversionofthefirstdemyelinatingeventtomultiplesclerosisacochranereviewonuseofrecombinantinterferonbetaorglatirameracetate